To explore the potential role of STAT3 in IL-17-mediated effects on NSCLC angiogenesis, STAT3 expression was reduced by small interfering RNA (siRNA) (Fig. S2). This evidence concerns the gene STAT3 and non-small cell lung carcinoma.